The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
Autor: | Skrypek N, Vasseur R, Vincent A, Belinda Duchêne, Van Seuningen I, Jonckheere N |
---|---|
Zdroj: | Europe PubMed Central |
Databáze: | OpenAIRE |
Externí odkaz: |